Matquez, Rehzie A.

HRN: 22-49-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
CEFUROXIME 1.5GM (VIAL)
01/20/2023
01/26/2023
IVT
1.5g
Q8
UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Choice  Wrong Choice

Overall appropriateness: No  Wrong Choice

Intervention



Type of Intervention done:

                    

           


Acceptance: